The early stage company is developing a new approach to gene editing to treat rare genetic diseases. It does this using mRNA, ...
Hosted on MSN21h
Morgan Stanley Downgrades Intellia Therapeutics (NTLA)Fintel reports that on January 27, 2025, Morgan Stanley downgraded their outlook for Intellia Therapeutics (NasdaqGM:NTLA) from Overweight to Equal-Weight. Analyst Price Forecast Suggests 449.14% ...
Stocktwits on MSN23h
Intellia Stock Dips After Morgan Stanley Downgrade, Retail Sentiment WeakensIntellia Therapeutics, Inc. shares declined over 5% on Monday morning after Morgan Stanley downgraded the stock to ‘Equal ...
"This is a sad day for democracy and a sad day for our judicial system," the justice minister said in a statement. Information ...
Virgin Voyages has kicked off 2025 with a bang, with a 60 percent increase in revenue and a 40 percent jump in new bookings. MSC Cruises is bringing its fourth World-class ship to a world class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback